Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
20 stocks in the US match these filters · market cap, largest first. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| VX1.DE | Vertex Pharmaceuticals Incorporated | Rare disease | $140.77B | 469.95 EUR | −1.05% | +10.56% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | Rare disease | $140.14B | 88.83 BRL | −87.14% | +19.14% |
| VRTX | Vertex Pharmaceuticals Incorporated | Rare disease | $140.04B | $552.85 | −0.51% | +15.42% |
| 0QZU.L | Vertex Pharmaceuticals Incorporated |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| Rare disease |
| $112.52B |
| $554.44 |
| −0.19% |
| +1.12% |
| 0HD2.L | Alnylam Pharmaceuticals, Inc. | Rare disease | $35.05B | $240.20 | −51.98% | −4.67% |
| ALNY | Alnylam Pharmaceuticals, Inc. | Rare disease | $32.12B | $240.08 | −51.55% | −13.76% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | Rare disease | $31.87B | 200.50 EUR | −50.80% | −20.91% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | Rare disease | $31.78B | 61.14 BRL | −53.82% | −11.65% |
| INSM | Insmed Incorporated | Rare disease | $27.07B | $123.89 | −41.77% | +18.29% |
| BBIO | BridgeBio Pharma, Inc. | Rare disease | $15.85B | $80.40 | −13.93% | −4.42% |
| CORT | Corcept Therapeutics Incorporated | Rare disease | $13.36B | $123.57 | −2.23% | +35.61% |
| 0JAV.L | Insmed Incorporated | Rare disease | $12.89B | $125.32 | −41.44% | +0.69% |
| BMRN | BioMarin Pharmaceutical Inc. | Rare disease | $12.80B | $66.12 | −6.85% | +9.71% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | Rare disease | $12.54B | 166.77 BRL | −4.38% | +12.08% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | Rare disease | $12.52B | $88.88 | −6.92% | +3.92% |
| CYTK | Cytokinetics, Incorporated | Rare disease | $10.77B | $77.46 | −12.29% | −3.92% |
| IONS | Ionis Pharmaceuticals, Inc. | Rare disease | $10.56B | $63.57 | −26.71% | +13.60% |
| KYMR | Kymera Therapeutics, Inc. | Rare disease | $10.53B | $126.64 | −2.62% | +15.07% |
| 0JDI.L | Ionis Pharmaceuticals, Inc. | Rare disease | $10.40B | $63.80 | −26.45% | +4.15% |
| PTGX | Protagonist Therapeutics, Inc. | Rare disease | $10.01B | $150.59 | −6.36% | +11.09% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.